Chronic allograft nephropathy and nephrotic range proteinuria

Area of Science:

• Nephrology
• Transplantation Immunology
• Renal Pathology

Background:

• Post-transplant nephrotic range proteinuria (PTx-NP) is linked to chronic allograft nephropathy (CAN).
• Factors influencing graft survival in patients with PTx-NP and CAN remain unclear.
• Understanding these factors is crucial for improving outcomes in kidney transplant recipients.

Purpose of the Study:

• To investigate the factors determining graft survival in patients with biopsy-proven CAN and PTx-NP.
• To stratify patients based on the timing of PTx-NP onset.
• To evaluate the impact of renal function and proteinuria levels on allograft survival.

Main Methods:

• Retrospective analysis of 30 patients with biopsy-proven CAN and PTx-NP (1988-2002).
• Stratification into groups based on PTx-NP onset (<1 yr vs. >1 yr post-transplant).
• Comparison of graft survival based on serum creatinine levels, proteinuria, and ACE inhibitor use.

Main Results:

• Graft loss was high in both PTx-NP onset groups (89% vs. 83%).
• Patients with serum creatinine ≤2 mg/dL at biopsy had significantly better graft survival (75% vs. 4%, p=0.0038).
• Proteinuria magnitude (>3 gm/d) and ACE inhibitor use did not significantly impact graft survival.

Conclusions:

• PTx-NP associated with CAN portends poor allograft survival.
• Reduced renal function at the time of biopsy is a critical predictor of poor graft survival.
• Early identification and management strategies targeting renal function are essential for improving outcomes.